CIK 0000921299
- Non-accelerated filer
- Smaller reporting company
KYNTRA BIO, INC.
Sign in to watch- Ticker
- KYNB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 770357827
- Phone
- +1 415-978-1200
- Business address
- 350 BAY STREET, SUITE 100 #6009, SAN FRANCISCO, CA, 94133
- Former names
- FIBROGEN INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-06-19 | Chung Christine SVP, China Operations | Exercise or conversion · Stock Option (Right to Buy) | −5,625 | 14,584 | ||
| 2019-06-18 | Kouchakji Elias SVP, Clinical Dev, Drug Safety | Exercise or conversion | +16,000 | $14.58 | $233K | 112,072 |
| 2019-06-18 | Kouchakji Elias SVP, Clinical Dev, Drug Safety | Exercise or conversion · Stock Option (Right to Buy) | −16,000 | 7,082 | ||
| 2019-06-18 | Cotroneo Pat SVP, Finance and CFO | Sale | −3,201 | $43.12 | $138K | 250,777 |
| 2019-06-18 | Chung Christine SVP, China Operations | Exercise or conversion | +2,120 | $29.66 | $63K | 157,195 |
| 2019-06-18 | Chung Christine SVP, China Operations | Sale | −5,625 | $44.08 | $248K | 151,570 |
| 2019-06-18 | Chung Christine SVP, China Operations | Exercise or conversion · Stock Option (Right to Buy) | −2,120 | 20,209 | ||
| 2019-06-14 | Yu K Peony Chief Medical Officer | Sale | −3,420 | $40.96 | $140K | 186,976 |
| 2019-06-12 | Yu K Peony Chief Medical Officer | Exercise or conversion | +10,698 | $14.58 | $156K | 190,396 |
| 2019-06-12 | Yu K Peony Chief Medical Officer | Exercise or conversion · Stock Option (Right to Buy) | −10,698 | 657 | ||
| 2019-06-10 | Blaug Suzanne Director | Grant or award | +4,648 | 4,648 | ||
| 2019-06-10 | Blaug Suzanne Director | Grant or award · Stock Option (Right to Buy) | +7,714 | 7,714 | ||
| 2019-06-10 | Blaug Suzanne Director | Grant or award · Stock Option (Right to Buy) | +10,400 | 10,400 | ||
| 2019-06-06 | Yu K Peony Chief Medical Officer | Shares withheld for taxes | −3,360 | $38.31 | $129K | 179,698 |
| 2019-06-06 | Neff Thomas B Chief Executive Officer | Exercise or conversion | +6,834 | $2.90 | $20K | 2,469,214 |
| 2019-06-06 | Neff Thomas B Chief Executive Officer | Sale | −6,900 | $37.57 | $259K | 2,462,314 |
| 2019-06-06 | Neff Thomas B Chief Executive Officer | Sale | −11,500 | $38.16 | $439K | 2,450,814 |
| 2019-06-06 | Neff Thomas B Chief Executive Officer | Shares withheld for taxes | −8,542 | $38.31 | $327K | 2,442,272 |
| 2019-06-06 | Neff Thomas B Chief Executive Officer | Sale | −800 | $37.77 | $30K | 59,036 |
| 2019-06-06 | Neff Thomas B Chief Executive Officer | Sale | −618 | $38.20 | $24K | 58,418 |
Page 32 of 33 · 651 trades